Dec. 15, 2005 (Atlanta) ― Patients with chronic myeloid leukemia (CML) treated with imatinib ( Gleevec) who initially achieved complete cytogenetic responses continue to show improvement at 4 years, ...
Poitiers, Sunday 5th December 2004 -- CHU in Poitiers, France, today announced results of a study showing that newly diagnosed patients with a certain form of leukemia who are treated early with ...
(ATLANTA, December 10, 2005) – Offering promise in the battle against cancer, the results from five studies highlighting new advances in the treatment of chronic myeloid leukemia (CML) – a ...